REL

RELX is not a publishing company. It has not been one for over a decade, despite its historical lineage as Reed Elsevier, a name associated with scientific journals and legal directories. The transformation that CEO Erik Engstrom has overseen since 2009 has quietly repositioned the firm as one of Europe's most structurally powerful businesses: a provider of data analytics and decision tools so deeply embedded in customer workflows that switching them out would disrupt the daily operations of hospitals, law firms, insurance underwriters, and research institutions worldwide.

The central analytical question for RELX is not whether it has a moat. It does. The question is whether the moat is deepening or whether generative AI and open-access movements threaten to erode the very data monopolies that underpin its pricing power. The answer, as of mid-2026, is that the moat is compounding. RELX's four-segment structure (Risk, Scientific Technical and Medical, Legal, and Exhibitions) creates a diversified earnings base, but the real story is in the first three: each operates as a near-monopoly information utility in its respective professional domain. Competitors do not define themselves relative to RELX because they aspire to replace it. They define themselves relative to RELX because they have no choice; the company's datasets and analytics tools are the reference standard against which professional alternatives are measured.

With revenue reaching GBP 9.59 billion in FY2025, EBIT margins above 31%, and free cash flow of GBP 2.86 billion, this is a business that converts intellectual property into cash at a rate that rivals the best software companies in the world. The market capitalization sits near GBP 45 billion, and the company trades at roughly 27 times trailing earnings. That premium is not an accident. It is the market's recognition that RELX possesses something exceedingly rare: structural pricing power over professional customers who cannot easily leave.